Imunon Reports Q3 2026 Net Loss of $3.8 Million and Advances IMNN-001

Imunon reported a net loss available to common shareholders of $3.8 million, or $0.64 per share, for the third quarter of 2026, compared with $3.4 million, or $1.16 per share, a year earlier. Operating expenses were $3.4 million for the quarter. The company also provided updates on its Phase 3 ovar…